期刊文献+

3-(S)-(1-氨甲酰基-1,1-二苯甲基)吡咯烷的合成 被引量:1

Synthesis of 3-(S)-(1-Carbamoyl-1,1-diphenylmethyl) pyrrolidine
原文传递
导出
摘要 反式-4-羟基-L-脯氨酸经脱羧、N-Boc保护和氯代反应制得N-Boc-3-(S)-氯吡咯烷,在叔丁醇钾作用下与二苯乙腈缩合得N-Boc-3-(S)-(1-氰基-1,1-二苯甲基)吡咯烷,再经水解、脱保护、经L-(+)-酒石酸处理后碱化制得氢溴酸达非那新中间体3-(S)-(1-氨甲酰基-1,1-二苯基甲基)吡咯烷,总收率约14%。 3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine,an intermediate of derifenacin hydrobromide,was synthesized from trans-4-hydroxy-L-proline by decarboxylation,N-Boc protection and chlorination to give N-Boc-3-(S)-chloropyrrolidine,which was subjected to condensation with diphenylacetonitrile in presence of potassium t-butoxide,hydrolysis,deprotection,treatment with L-(+)-tartaric acid and then alkalization.The overall yield was about 14%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第4期251-253,共3页 Chinese Journal of Pharmaceuticals
基金 中央高校基本科研业务费专项资金(2010LKHX4)
关键词 3-(S)-(1-氨甲酰基-1 1-二苯基甲基)吡咯烷 氢溴酸达非那新 中间体 合成 3-(S)-(1-carbamoyl-1 1-diphenylmethyl)pyrrolidine derifenacin hydrobromide intermediate synthesis
  • 相关文献

参考文献10

  • 1靳磊,罗峰,林蓉,黄文才,李子成.氢溴酸达非那新的合成[J].中国医药工业杂志,2010,41(3):167-170. 被引量:4
  • 2刘长欢,俞雄,袁哲东.氢溴酸达非那新的合成[J].中国医药工业杂志,2007,38(12):825-827. 被引量:10
  • 3Braverman AS,,Tibb AS,Ruggieri MR.M2 and M3muscarinic receptor activation of urinary bladder contractilesignal transduction.I.Normal rat bladder. Journal of Pharmacology and Experimental Therapeutics . 2006
  • 4Dunn PJ,Matthews JG,Newbury TJ,et al.Stable hydrateof a muscarinic receptor antagonist. US,7696357 . 2010
  • 5Valeriano M,Augusto C.Processes for preparing darifenacinhydrobromide. WO,2007076158 . 2007
  • 6Nuria SM.Process for preparing 3-substituted pyrrolidinecompounds. WO,2009153649 . 2009
  • 7Houghton PG,Humphrey GR,Kennedy DJ,et al.Enantiospecific synthesis of the (4R)-1-azabicyclo[2.2.1]heptane ring system. Journal of the Chemical Society . 1993
  • 8Zinner N.Darifenacin:a muscarinic M3-selective receptorantagonist for the treatment of overactive bladder. ExpertOpin Pharmacother . 2007
  • 9Cross PE,Mackeazie AR.Preparation of pyrrolidine derivatives as muscarinic receptor antagonists. EP,0338054 . 1990
  • 10Berger,Y,Dehmlow,H,Blum-Kaelin,D,Kitas,EA,Loffler,BM,Aebi,JD,Juillerat-Jeanneret,L.Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. Journal of Medicinal Chemistry . 2005

二级参考文献14

  • 1Nunn PA, Greengrass PM, Newgreen DT, et al. The binding profile of the novel muscarinic receptor antagonist the five cloned human muscarinic receptors expressed in CHO cells [J]. Br J Pharmacol, 1996, 117: 130.
  • 2Newgreen DT, Anderson DW, Carter AJ. Darifenacin: a novel bladder-selective muscarinic antagonist for the treatment of urge incontinence [J]. J Urol, 1996, 155: 156.
  • 3Alabaster RJ, Cottrell IF. The synthesis of 5-substituted 2,3-dihydrobenzofunars [J]. Synthesis, 1988, 27: 950-952.
  • 4Dunn JP, Ackerman NA, Tomolonis AJ. Analgetic and antiinflammatory 7-aroylbenzofuran-5-ylacetic acids and 7-aroylbenzothiophene-5-ylacetic acids[J]. J Med Chem, 1986, 29 (11) : 2326-2329.
  • 5Nystrom RF, Brown WG. Reduction organic compounds by lithium aluminum hydride.Ⅱ . Carboxylic acids [J]. J Am Chem Soc, 1947, 69 (10) : 2548-2549.
  • 6Cross PE, Mackenzie AR. Pyrrolidine derivatives: EP, 0388054 [P]. 1990-09-19. (CA 1991, 114: 247125).
  • 7Dunn P J, Matthews JG, Newbury T J, et al. Stable hydrate of a muscarinic receptor antagonist: US, 6930188 [P]. 2005-08-16. (CA 2003, 139: 292143).
  • 8郑静,方霞.5-乙酰基-2,3-二氢苯并呋喃的合成[J].精细化工中间体,2007,37(4):34-35. 被引量:2
  • 9Nunn PA, Greengrass PM, Newgreen DT, et al. The binding profile of the novel muscarinic receptor antagonist the five cloned human muscarinic receptors expressed in CHO cells [J]. Br JPharmacol, 1996, 117 (suppl) : 130P.
  • 10Newgreen DT, Anderson DW, Carter AJ. Darifenacin: a novel bladder-selective muscarinic antagonist for the treatment of urge incontinence [J]. J Urol, 1996, 155 (suppl. 5) : 156.

共引文献10

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部